|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/155 | (2006.01) |
| (11) | Number of the document | 3067064 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16166033.7 |
| Date of filing the European patent application | 2009-12-09 | |
| (97) | Date of publication of the European application | 2016-09-14 |
| (45) | Date of publication and mention of the grant of the patent | 2020-05-13 |
| (46) | Date of publication of the claims translation | 2020-09-10 |
| (30) | Number | Date | Country code |
| 121126 P | 2008-12-09 | US | |
| 169077 P | 2009-04-14 | US | |
| 224787 P | 2009-07-10 | US |
| (72) |
PUSHKO, Peter, US
WU, Yingyun, US
MASSARE, Michael, US
LIU, Ye, US
SMITH, Gale, US
ZHOU, Bin, US
|
| (73) |
Novavax, Inc.,
21 Firstfield Rd,, Gaithersburg, MD 20878,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Modifikuoti RSV F baltymai ir jų panaudojimo būdai |
| MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE |
| Payment date | Validity (years) | Amount | |
| 2024-11-19 | 16 | 347.00 EUR |
| 2025-12-09 |